NEUROLOGICAL DISORDER DIAGNOSTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Neurological Disorder Diagnostics - Overview Global Neurological Disorder Diagnostics Market, by Technology (Imaging, and In Vitro Diagnostics), by Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), by End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is expected to be valued at US$ 12,162.6 million in 2019 and is expected to exhibit a CAGR of 7.6% over the forecast period (2019-2027). The increasing number of research and development of novel diagnostic technology by key players is the factor that is expected to drive growth of the global neurological disorder diagnostics market over the forecast period. For instance, in 2017, researchers from Assistance Publique – Hôpitaux de Paris (AP-HP) entered into a collaboration with researchers from ICM (Institut du Cerveau et de la Moelle Epinière) Paris, Brain And Spinal Institute, and Metafora Biosystems to develop a diagnostic blood test for De Vivo disease, a rare neurological illness. Development of such novel methods is expected to create lucrative environment for growth of the in-vitro diagnostics segment. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/facial-rejuvenation-market-3189
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION In addition, market players are focusing on development of novel products for diagnosis of neurological disorders, which is expected to drive growth of the market over the forecast period. For instance, in March 2018, Oxford BioDynamics Plc. presented clinical trial data of its novel EpiSwitch test to diagnose Amyotrophic Lateral Sclerosis (ALS), a genetic neurological disorder. EpiSwitch is a non-invasive test to diagnose ALS that could yield results within a day. Similarly, in January 2018, PerkinElmer, Inc. launched a new in-vitro diagnostic (IVD) kit for screening of a genetic neurological disorder, Duchenne Muscular Dystrophy (DMD). Browse 36 Market Data Tables and 30 Figures spread through 237 Pages and in-depth TOC on “Neurological Disorder Diagnostics Market” Global Forecast to 2027, by Technology (Imaging, and In Vitro Diagnostics), by Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), by End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/1867
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION • Key Takeaways of the Global Neurological Disorder Diagnostics Market:
•The global neurological disorder diagnostics market is expected to exhibit a CAGR of 7.6% over the forecast period (2019-2027), attributed to frequent product launches, regulatory product approvals, and increasing research and development of novel products by key players. For instance, in April 2018, Siemens Healthineers received the U.S. FDA approval for its new SOMATOM go.All and SOMATOM go.Top computed tomography (CT) systems. SOMATOM go.All has 64-slice and provides 0.33-second rotation time, stellar detector technology, and a robust 75 kW generator. SOMATOM go.Top has 128-slice and provides a fast scanning. •Among regions, North America held a dominant position in the global neurological disorder diagnostics market in 2018 and is expected to retain its dominance over the forecast period (2019-2027). The regional growth is attributed to increasing number of approvals of novel neurological diagnostic tools by regulatory bodies in the region. For instance, in January 2018, Masimo Corporation announced to rceive the U.S. Food & Drug Administration clearance of its SedLine brain function monitoring system.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1867 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved